Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control

Míreanna comhchosúla

• Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial
  de réir: Wajja, A, et al.
  Foilsithe / Cruthaithe: (2023)
• The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial
  de réir: Wajja, A, et al.
  Foilsithe / Cruthaithe: (2017)
• The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
  de réir: Anne Wajja, et al.
  Foilsithe / Cruthaithe: (2017-05-01)
• Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A
  de réir: Wajja, A, et al.
  Foilsithe / Cruthaithe: (2018)
• DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
  de réir: Mcshane, H
  Foilsithe / Cruthaithe: (2008)